ChemDiv 2


Number of compounds

8,560

Plate Numbers

1369-1393 (25 plates)

Concentration Information

5 mg/ml in DMSO

Plate Format

384-well plate

Plates 1369-1371, 1373-1386, 1388-1392:
Column 23-24 (empty)

Click plate image to enlarge


Plate 1372:
Column 21 [E, G, I, K, M, O] (empty)
Column 23-24 (empty)

Click plate image to enlarge


Plate 1387:
Column 1-2 (empty)

Click plate image to enlarge


Plate 1393:
Column 2, 4, 6 (empty)
Column 7 [N] (empty)
Column 8 (empty)
Column 9 [B, D, F, H, J, L, N, P] (empty)
Column 10 (empty)
Column 11 [B, D, F, H, J, L, N, P] (empty)
Column 12 (empty)
Column 13 [B, D, F, H, J, L, N, P] (empty)
Column 14 (empty)
Column 15 [B, D, F, H, J, L, N, P] (empty)
Column 16 (empty)
Column 17 [B, D, F, H, J, L, N, P] (empty)
Column 18 (empty)
Column 19 [B, D, F, H, J, L, N, P] (empty)
Column 20 (empty)
Column 21 [B, D, F, H, J, L, N, P] (empty)
Column 22-24 (empty)

Click plate image to enlarge

 

This collection was purchased jointly with the New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases (NERCE) and the Laboratory for Drug Discovery for Neurodegeneration (LDDN) in June 2004 . Funding was provided by NERCE and the Dana Farber/Harvard Cancer Center (DF/HCC) Cancer Drug Assays program (CDA). With the assistance of Dr. Tudor Oprea at the University of New Mexico, these compounds were specifically chosen to increase the overall diversity of the ICCB-Longwood collection, and were also selected for favorable physico-chemical properties, such as solubility, decreased toxicity, and increased stability.

Contact Information for ChemDiv:

Please send all order requests and questions to
Coleen DeAngelo (cmd@chemdiv.com) or Viatcheslav Katin (vk@chemdiv.com).

http://www.chemdiv.com/